about
An unusual cutaneous tumor: African histoplasmosis following mudbaths: case report and reviewSubstandard/counterfeit antimicrobial drugsA high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLMechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.Giant right atrium with severe pulmonary hypertension.Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study.Maternal diet and cord blood leptin and adiponectin concentrations at birth.Adiponectin and cancer: a systematic reviewPlasma adiponectin concentrations and risk of incident breast cancer.Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.How to approach and treat viral infections in ICU patientsA biochemical fluorometric method for assessing the oxidative properties of HDL.HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque.Preexposure prophylaxis for HIV prevention.In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.De novo daptomycin-nonsusceptible enterococcal infections.Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.γH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianiiBiomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot studyThe emerging role of leptin in humans.Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260sDysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adultsIsolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood.Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.Human infections associated with wild birds.Untrained young men have dysfunctional HDL compared with strength-trained men irrespective of body weight statusDyslipidemia and cardiovascular risk in human immunodeficiency virus infection.The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection.Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study.Postirradiation Klebsiella pneumoniae-associated necrotizing fasciitis in the western hemisphere: a rare but life-threatening clinical entity.Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.Emphysematous cystitis in the absence of known risk factors: an unusual clinical entity.Cytomegalovirus pseudotumor of the duodenum in a patient with AIDS: an unrecognized and potentially treatable clinical entity.Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.
P50
Q26853525-9C3C089F-B5FD-4A0F-884B-EA413B5B9AB3Q27009319-6BECF45E-C22F-4516-96A9-B468F64EBE7EQ28544713-B64E5A94-E3BA-4D70-BFA8-2927063A72F3Q33648052-E5247D21-0DF0-4FFF-A7F0-4B8331624F46Q33678496-793C6964-BA1B-40B3-9014-B92200543182Q33925668-8860DA5A-303A-4C9C-93F9-C7CF8F166363Q34043959-7EC398D3-4ED2-4D89-9B32-EFD97B4AB5E1Q34506490-9EC93C3E-0654-4686-9D55-CF201BB24C16Q34599898-F59FECEE-4089-4DDE-96CC-4CB9C65597F9Q34803735-E90F0EF6-69D5-4349-A1EC-FBD8CBC65834Q34894660-EBAAAF5B-B025-4EA0-80A2-5CD2543DCD2DQ35562004-9ED4B2D0-BF2A-473C-BF87-C01968CD67BFQ35579905-EA71E179-6572-43F6-AF0C-56AE51583F54Q35717688-BFAE214F-40F8-4BEE-8B97-D47FD4875C8FQ35746209-FE0AFF08-45D6-4292-BE2C-EBFD60CA1A90Q35844661-50397168-C723-4431-9D4E-CD7649D100EFQ35974422-7FA13779-8100-4A0E-8C46-013DE95032B6Q36078749-EC1DF616-DCFD-48DE-A64A-8EE315C80A1AQ36130121-684B1C20-7D7D-49B9-BD72-8E0E4DE2DD4EQ36258783-B2E1F98F-7BFD-4135-8BA1-469D834AB5A9Q36290299-E6CAD09D-9AC4-4A7F-B514-C075D3FB9564Q36330954-1F42DE46-1A98-47EE-9F63-2F20E4ADC9BAQ36430090-7F74E597-62BE-4439-8FA7-4280B9E25D44Q36460394-BE126FA5-9FBD-4719-A06F-05B0B3231FFAQ36676379-5225069C-7758-43CD-8811-86A276490DCBQ36697990-275A52DB-464A-48F4-B319-04E1C2AB9A32Q36747601-EA706E22-F643-419A-AB52-F946335E2F89Q36842216-4DFFCC91-4E73-4CDD-B900-8ED20FCE00ECQ37039148-5CAAE79F-D53A-46CB-9DF1-092B84F7A2BCQ37235070-2F547E51-608B-41FE-A5AF-5F81FDCFF0E5Q37319195-7A378F0C-5397-49B2-8AF6-A4A3D406E55AQ37324462-D76ADEC8-65C3-4F99-88E0-A0DA9312CAEFQ37344527-1356B046-05BA-4E66-9A24-B5E025B2CB0EQ37386817-44EC0A3A-A078-4572-ABF2-29DFBAF7B3A4Q37542853-D519300A-DD86-4C46-83C3-CD03B61DEBB4Q37546815-06970446-C887-4181-9B17-DC33A7CF43FCQ37577291-B28EE741-2A2E-495F-861F-44EBF6F645DDQ37583229-E362DFDB-4430-4BC3-9324-FFED124A469CQ37670259-C708DE5C-502E-426A-8656-06440B9D801CQ37690999-7F146D39-AA0E-439B-9E23-4901EA7A9BA8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Theodoros Kelesidis
@ast
Theodoros Kelesidis
@en
Theodoros Kelesidis
@es
Theodoros Kelesidis
@nl
Theodoros Kelesidis
@sl
type
label
Theodoros Kelesidis
@ast
Theodoros Kelesidis
@en
Theodoros Kelesidis
@es
Theodoros Kelesidis
@nl
Theodoros Kelesidis
@sl
prefLabel
Theodoros Kelesidis
@ast
Theodoros Kelesidis
@en
Theodoros Kelesidis
@es
Theodoros Kelesidis
@nl
Theodoros Kelesidis
@sl
P106
P1153
35264189700
P21
P31
P496
0000-0002-8463-3811